empty
 
 
cn
搜索
支持
即时开户
交易平台
入金/出金
搜索
面向初学者 对于交易者 对于合作伙伴 休息一下 About InstaSpot
cn
For Traders
Charts
#DVAX

#DVAX (Dynavax Technologies Corporation). 汇率和在线图表。

#DHR 返回工具列表 #DXCM

货币转换器

Dynavax Technologies Corporation
18.5 USD
13 Feb 2026 22:12
价格变化 (% chg)
$3.01
(16.27%)
前收
前收

前一天收盘价
$18.5
开盘
开盘

开盘价。
$18.5
当日高点
当日高点

最后一个交易日的最高价。
$18.5
当日低点
当日低点

最后一个交易日的最低价。
$18.5
52周高点
52周高点

在过去52周的价格区间高点
$18.5
52周低点
52周低点

在过去52周的价格区间低点
$18.5
下载档案
Buy
18.53
Sell
18.5
以全屏视图打开图表
Buy
18.53
Sell
18.5
下载档案
以全屏视图打开图表

Dynavax Technologies Corporation. About company

Dynavax Technologies Corporation is a biopharmaceutical company whose core business is the development and production of vaccines.

The company’s main product is a hepatitis B drug. The company also produces vaccines against coronavirus, influenza, plague, and other infectious diseases.

In addition, the company is mainly focused on the production of adjuvants. These substances help vaccines to be better absorbed by the body.

Currently, Dynavax has a market capitalization of $1.37 billion. Last year, the company posted revenues of $438.24 million and a net income of $76.71 million.

Dynavax Technologies Corporation’s shares and what affects their price

Dynavax shares have been trading on the NASDAQ exchange under the DVAX ticker since 2004. The initial price per share stood at $7.50.

Currently, the company’s shares are trading between $10 and $12. During the year, the share price was hovering between $7 and $22. At the same time, the company does not pay dividends to its shareholders.

What to pay attention to when trading the company’s shares:

  • Long-term growth prospects are driven by a large number of innovative developments;
  • The target price for the stock is several times higher than the current one, ranging between $45.5 and $48, according to forecasts;
  • Adjuvant technology is an advantage for the company since these additional substances significantly enhance the effect of the vaccines.

现在无法通话？
提出您的问题，用 在线帮助.